Buoyed by clinical success, Onward Medical charts future of neurostimulation

Onward Medical is betting big on neurostimulation as a tool to improve the quality of life for people with paralysis, said CEO Dave Marver.

Bullish after recent clinical success, Marver spoke about the Swiss-Dutch company’s future plans at the 2024 STAT Summit in Boston, including a device that can better regulate an underactive bladder. 

“We’re doing it because it seems to work, and thus far, there’s been a lot of promising early feasibility clinical research,” he said. “We’re going to keep moving everything to the pipeline, doing larger studies and demonstrating the efficacy and safety of these devices as we move towards commercialization.”

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Individual plans

Group plans

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$20

for 3 months, then $399/year

$20 for 3 months Get Started

Then $399/year

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

Log In